Book Text

REFERENCES

151. Johnston P, Findlow D, Aldridge LM, et al: The effect of ketamine on 0.25% and 0.125% bupivacaine for caudal epidural blockade in children. Paediatr Anaesth 9:31–34, 1999.

152. Malinovsky JM, Lepage JY, Cozian A, et al: Is ketamine or its preservative responsible for neurotoxicity in the rabbit? Anesthesiology 78:109–115, 1993.

153. Klotz U, Avant GR, Hoyumpa A, et al: The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 55:347–359, 1975.

154. Morselli PL, Principi N, Tognoni G, et al: Diazepam elimination in premature and full term infants, and children. J Perinat Med 1:133–141, 1973.

155. Buhrer M, Maitre PO, Crevoisier C, et al: Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam. Clin Pharmacol Ther 48:555–567, 1990.

156. Jacqz-Aigrain E, Wood E, Robieux I: Pharmacokinetics of midazolam in critically ill neonates. Eur J Clin Pharmacol 36:191–192, 1990.

157. Burtin P, Jacqz-Aigrain E, Girard P, et al: Population pharmacokinetics of midazolam in neonates. Clin Pharmacol Ther 56:615–625, 1994.

158. Burtin P, Daoud P, Jacqz-Aigrain E, et al: Hypotension with midazolam and fentanyl in the newborn. Lancet 337:1545–1546, 1991.

159. Cray SH, Dixon JL, Heard CM, et al: Oral midazolam premedication for paediatric day case patients. Paediatr Anaesth 6:265–270, 1996.

160. Davis PJ, Tome JA, McGowan FX Jr, et al: Preanesthetic medication with intranasal midazolam for brief pediatric surgical procedures. Effect on recovery and hospital discharge times. Anesthesiology 82:2–5, 1995.

161. Fosel T, Hack C, Knoll R, et al: Nasal midazolam in children, plasma concentrations and the effect on respiration. Paediatr Anaesth 5:347–353, 1995.

162. Malinovsky JM, Populaire C, Cozian A, et al: Premedication with midazolam in children. Effect of intranasal, rectal and oral routes on plasma midazolam concentrations. Anaesthesia 50:351–354, 1995.

163. Spear RM, Yaster M, Berkowitz ID, et al: Preinduction of anesthesia in children with rectally administered midazolam. Anesthesiology 74:670–674, 1991.

164. Coté CJ, Cohen IT, Suresh S, et al: A comparison of three doses of a commercially prepared oral midazolam syrup in children. Anesth Analg 94:37–43, 2002.

165. Karl HW, Keifer AT, Rosenberger JL, et al: Comparison of the safety and efficacy of intranasal midazolam or sufentanil for preinduction of anesthesia in pediatric patients. Anesthesiology 76:209–215, 1992.

166. Olkkola KT, Aranko K, Luurila H, et al: A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther 53:298–305, 1993.

167. Bailey DG, Malcolm J, Arnold O, et al: Grapefruit juice-drug interactions. Br J Clin Pharmacol 46:101–110, 1998.

168. Palkama VJ, Ahonen J, Neuvonen PJ, et al: Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam. Clin Pharmacol Ther 66:33–39, 1999.

169. Malinovsky JM, Cozian A, Lepage JY, et al: Ketamine and midazolam neurotoxicity in the rabbit. Anesthesiology 75:91–97, 1991.

170. Committee on Drugs, American Academy of Pediatrics: Alternate routes of drug administration—advantages and disadvantages. Pediatrics 100:143–152, 1997.

171. Kupferberg HJ, Way HJ: Pharmacologic basis for the increased sensitivity of the newborn to morphine. J Pharmacol Exp Ther 141:105–109, 1963.

172. Lynn AM, Slattery JT: Morphine pharmacokinetics in early infancy. Anesthesiology 66:136–139, 1987.

173. Bragg P, Zwass MS, Lau M, et al: Opioid pharmacodynamics in neonatal dogs: Differences between morphine and fentanyl. J Appl Physiol 79:1519–1524, 1995.

174. Way WL, Costley EC, Way EI: Respiratory sensitivity of the newborn infant to meperidine and morphine. Clin Pharmacol Ther 6:454–461, 1965.

175. Pokela ML, Olkkola KT, Koivisto M, et al: Pharmacokinetics and pharmacodynamics of intravenous meperidine in neonates and infants. Clin Pharmacol Ther 52:342–349, 1992.

176. Armstrong PJ, Bersten A: Normeperidine toxicity. Anesth Analg 65:536–538, 1986.

177. Singleton MA, Rosen JI, Fisher DM: Plasma concentrations of fentanyl in infants, children and adults. Can J Anaesth 34:152–155, 1987.

178. Yaster M: The dose response of fentanyl in neonatal anesthesia. Anesthesiology 66:433–435, 1987.

179. Gauntlett IS, Fisher DM, Hertzka RE, et al: Pharmacokinetics of fentanyl in neonatal humans and lambs: Effects of age. Anesthesiology 69:683–687, 1988.

180. Kuhls E, Gauntlett IS, Lau M, et al: Effect of increased intra-abdominal pressure on hepatic extraction and clearance of fentanyl in neonatal lambs. J Pharmacol Exp Ther 274:115–119, 1995.

181. Feld LH, Champeau MW, van Steennis CA, et al: Preanesthetic medication in children: A comparison of oral transmucosal fentanyl citrate versus placebo. Anesthesiology 71:374–377, 1989.

182. Preston RA, Csontos ER, East KA, et al: Plasma fentanyl concentrations after oral transmucosal fentanyl citrate: Children versus adults. Anesthesiology 79:A370, 1993.

183. Epstein RH, Mendel HG, Witkowski TA, et al: The safety and efficacy of oral transmucosal fentanyl citrate for preoperative sedation in young children. Anesth Analg 83:1200–1205, 1996.

184. Friesen RH, Lockhart CH: Oral transmucosal fentanyl citrate for preanesthetic medication of pediatric day surgery patients with and without droperidol as a prophylactic anti-emetic. Anesthesiology 76:46–51, 1992.

185. Ashburn MA, Streisand JB, Tarver SD, et al: Oral transmucosal fentanyl citrate for premedication in paediatric outpatients. Can J Anaesth 37:857–866, 1990.

186. Schutzman SA, Burg J, Liebelt E, et al: Oral transmucosal fentanyl citrate for premedication of children undergoing laceration repair. Ann Emerg Med 24:1059–1064, 1994.

187. Weisman SJ, Bernstein B, Schechter NL: Consequences of inadequate analgesia during painful procedures in children. Arch Pediatr Adolesc Med 152:147–149, 1998.

188. Dsida RM, Wheeler M, Birmingham PK, et al: Premedication of pediatric tonsillectomy patients with oral transmucosal fentanyl citrate. Anesth Analg 86:66–70, 1998.

189. Wheeler M, Birmingham PK, Dsida RM, et al: Uptake pharmacokinetics of the Fentanyl Oralet in children scheduled for central venous access removal: Implications for the timing of initiating painful procedures. Paediatr Anaesth 12:594–599, 2002.

190. Wheeler M, Birmingham PK, Lugo RA, et al: Pharmacokinetics of the intravenous formulation of fentanyl citrate administered orally in children undergoing general anesthesia. Anesth Analg (in press).

191. Meuldermans W, Van Peer A, Hendrickx J, et al: Alfentanil pharmacokinetics and metabolism in humans. Anesthesiology 69:527–534, 1988.

192. Goresky GV, Koren G, Sabourin MA, et al: The pharmacokinetics of alfentanil in children. Anesthesiology 67:654–659, 1987.

193. Meistelman C, Saint-Maurice C, Lepaul M, et al: A comparison of alfentanil pharmacokinetics in children and adults. Anesthesiology 66:13–16, 1987.

194. Chauvin M, Bonnet F, Montembault C, et al: The influence of hepatic plasma flow on alfentanil plasma concentration plateaus achieved with an infusion model in humans: Measurement of alfentanil hepatic extraction coefficient. Anesth Analg 65:999–1003, 1986.

195. Greeley WJ, de Bruijn NP: Changes in sufentanil pharmacokinetics within the neonatal period. Anesth Analg 67:86–90, 1988.

2404

196. Starr NJ, Sethna DH, Estafanous FG: Bradycardia and asystole following the rapid administration of sufentanil with vecuronium. Anesthesiology 64:521–523, 1986.

197. Davis PJ, Lerman J, Suresh S, et al: A randomized multicenter study of remifentanil compared with alfentanil, isoflurane, or propofol in anesthetized pediatric patients undergoing elective strabismus surgery. Anesth Analg 84:982–989, 1997.

198. Kapila A, Glass PS, Jacobs JR, et al: Measured context-sensitive half-times of remifentanil and alfentanil. anesthesiology 83:968–975, 1995.

199. Ross AK, Davis PJ, Dear Gd GL, et al: Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg 93:1393–1401, 2001.

200. Davis PJ, Killian A, Stiller RL, et al: Pharmacokinetics of alfentanil in newborn premature infants and older children. Dev Pharmacol Ther 13:21–27, 1989.

201. Koehntop DE, Rodman JH, Brundage DM, et al: Pharmacokinetics of fentanyl in neonates. Anesth Analg 65:227–232, 1986.

202. Eck JB, Lynn AM: Use of remifentanil in infants. Paediatr Anaesth 8:437–439, 1998.

203. Davis PJ, Galinkin J, McGowan FX, et al: A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy. I. Emergence and recovery profiles. Anesth Analg 93:1380–1386, 2001.

204. Galinkin JL, Davis PJ, McGowan FX, et al: A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy. II. Perioperative breathing patterns in neonates and infants with pyloric stenosis. Anesth Analg 93:1387–1392, 2001.

205. Lynn AM: Remifentanil: The paediatric anaesthetist's opiate? Paediatr Anaesth 6:433–435, 1996.

206. Chiaretti A, Pietrini D, Piastra M, et al: Safety and efficacy of remifentanil in craniosynostosis repair in children less than 1 year old. Pediatr Neurosurg 33:83–88, 2000.

207. Donmez A, Kizilkan A, Berksun H, et al: One center's experience with remifentanil infusions for pediatric cardiac catheterization. J Cardiothorac Vasc Anesth 15:736–739, 2001.

208. DeSouza G, Lewis MC, TerRiet MF: Severe bradycardia after remifentanil. Anesthesiology 87:1019–1020, 1997.

209. Reyle-Hahn M, Niggemann B, Max M, et al: Remifentanil and propofol for sedation in children and young adolescents undergoing diagnostic flexible bronchoscopy. Paediatr Anaesth 10:59–63, 2000.

210. Munoz HR, Cortinez LI, Altermatt FR, et al: Remifentanil requirements during sevoflurane administration to block somatic and cardiovascular responses to skin incision in children and adults. Anesthesiology 97:1142–1145, 2002.

211. Keidan I, Berkenstadt H, Sidi A, et al: Propofol/remifentanil versus propofol alone for bone marrow aspiration in paediatric haemato-oncological patients. Paediatr Anaesth 11:297–301, 2001.

212. Liu LMP, DeCook TH, Goudsouzian NG, et al: Dose response to intramuscular succinylcholine in children. Anesthesiology 55:599–602, 1981.

213. Mazze RI, Dunbar RW: Intralingual succinylcholine administration in children: An alternative to intravenous and intramuscular routes? Anesth Analg 47:605–615, 1968.

214. Carroll JB: Increased incidence of masseter spasm in children with strabismus anesthetized with halothane and succinylcholine. Anesthesiology 67:559–561, 1987.

215. Schwartz L, Rockoff MA, Koka BV: Masseter spasm with anesthesia: Incidence and implications. Anesthesiology 61:772–775, 1984.

216. van der Spek AF, Fang WB, Ashton-Miller JA, et al: The effects of succinylcholine on mouth opening. Anesthesiology 67:459–465, 1987.

217. Mazurek AJ, Rae B, Hann S, et al: Rocuronium versus succinylcholine: Are they equally effective during rapid-sequence induction of anesthesia? Anesth Analg 87:1259–1262, 1998.

218. Meakin GH: Recent advances in myorelaxant therapy. Paediatr Anaesth 11:523–531, 2001.

219. Fisher DM, O'Keeffe C, Stanski DR, et al: Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults. Anesthesiology 57:203–208, 1982.

220. Gozal Y, Mints B, Drenger B: Time course of neuromuscular blockade with rocuronium in children with intracardiac shunts. J Cardiothorac Vasc Anesth 16:737–738, 2002.

221. Meretoja OA: Vecuronium infusion requirements in pediatric patients during fentanyl-N₂ O-O₂ anesthesia. Anesth Analg 68:20–24, 1989.

222. Goudsouzian NG: Atracurium infusion in infants. Anesthesiology 68:267–269, 1988.

223. Taivainen T, Meakin GH, Meretoja OA, et al: The safety and efficacy of cisatracurium 0.15 mg·kg⁻¹ during nitrous oxide-opioid anaesthesia in infants and children. Anaesthesia 55:1047–1051, 2000.

224. Fisher DM, Canfell PC, Fahey MR, et al: Elimination of atracurium in humans: Contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology 65:6–12, 1986.

225. Eliasson E, Kenna JG: Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol 50:573–582, 1996.

226. Bond GR: Hepatitis, rash and eosinophilia following trichloroethylene exposure: A case report and speculation on mechanistic similarity to halothane induced hepatitis. J Toxicol Clin Toxicol 34:461–466, 1996.

227. Meretoja OA, Wirtavuori K, Neuvonen PJ: Age-dependence of the dose-response curve of vecuronium in pediatric patients during balanced anesthesia. Anesth Analg 67:21–26, 1988.

228. Cook DR, Stiller RL, Weakly JN, et al: In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine. Anesth Analg 68:452–456, 1989.

229. Goudsouzian NG, d'Hollander AA, Viby-Mogensen J: Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 77:183–185, 1993.

230. Goudsouzian NG, Alifimoff JK, Eberly C, et al: Neuromuscular and cardiovascular effects of mivacurium in children. Anesthesiology 70:237–242, 1989.

231. Goudsouzian NG, Alifimoff JK, Liu LM, et al: Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane. Br J Anaesth 62:263–268, 1989.

232. Pittet JF, Tassonyi E, Morel DR, et al: Pipecuronium-induced neuromuscular blockade during nitrous oxide-fentanyl, isoflurane, and halothane anesthesia in adults and children. Anesthesiology 71:210–213, 1989.

233. Meretoja OA, Taivainen T, Erkola O, et al: Dose-response and time-course of effect of rocuronium bromide in paediatric patients. Eur J Anaesthesiol Suppl 11:19–22, 1995.

234. Vuksanaj D, Fisher DM: Pharmacokinetics of rocuronium in children aged 4–11 years. Anesthesiology 82:1104–1110, 1995.

235. Reynolds LM, Lau M, Brown R, et al: Intramuscular rocuronium in infants and children. Dose-ranging and tracheal intubating conditions. Anesthesiology 85:231–239, 1996.

236. Driessen JJ, Robertson EN, Van Egmond J, et al: Time-course of action of rocuronium 0.3 mg·kg⁻¹ in children with and without endstage renal failure. Paediatr Anaesth 12:507–510, 2002.

237. Mason LJ, Betts EK: Leg lift and maximum inspiratory force, clinical signs of neuromuscular blockade reversal in neonates and infants. Anesthesiology 52:441–442, 1980.

238. Coté CJ: Preoperative preparation and premedication. Br J Anaesth 83:16–28, 1999.

239. Suresh S, Wheeler M: Practical pediatric regional anesthesia. Anesthesiol Clin North Am 20:83–113, 2002.

240. Splinter WM, Schaefer JD: Unlimited clear fluid ingestion two hours before surgery in children does not affect volume or pH of stomach contents. Anaesth Intensive Care 18:522–526, 1990.

241. Schreiner MS, Treibwasser A, Keon TP: Ingestion of liquids compared with preoperative fasting in pediatric outpatients. Anesthesiology 72:593–597, 1990.

242. Coté CJ: NPO after midnight for children—a reappraisal. Anesthesiology 72:589–592, 1990.

2405

243. Litman RS, Wu CL, Quinlivan JK: Gastric volume and pH in infants fed clear liquids and breast milk prior to surgery. Anesth Analg 79:482–485, 1994.

244. Kain ZN, Mayes LC, Bell C, et al: Premedication in the United States: A status report. Anesth Analg 84:427–432, 1997.

245. Gutstein HB, Johnson KL, Heard MB, et al: Oral ketamine preanesthetic medication in children. Anesthesiology 76:28–33, 1992.

246. Miller BR, Friesen RH: Oral atropine premedication in infants attenuates cardiovascular depression during halothane anesthesia. Anesth Analg 67:180–185, 1988.

247. Fennelly ME, Hall GM: Anaesthesia and upper respiratory tract infections—a non-existent hazard? Br J Anaesth 64:535–536, 1990.

248. McGill WA, Coveler LA, Epstein BS: Subacute upper respiratory infection in small children. Anesth Analg 58:331–333, 1979.

249. Empey DW: Effect of airway infections on bronchial reactivity. Eur J Respir Dis Suppl 128:366–368, 1983.

250. Olsson GL, Hallen B: Laryngospasm during anaesthesia. A computer-aided incidence study in 136,929 patients. Acta Anaesthesiol Scand 28:567–575, 1984.

251. Schreiner MS, O'Hara I, Markakis DA, et al: Do children who experience laryngospasm have an increased risk of upper respiratory tract infection? Anesthesiology 85:475–480, 1996.

252. Cohen MM, Cameron CB: Should you cancel the operation when a child has an upper respiratory tract infection? Anesth Analg 72:282–288, 1991.

253. Tait AR, Malviya S, Voepel-Lewis T, et al: Risk factors for perioperative adverse respiratory events in children with upper respiratory tract infections. Anesthesiology 95:299–306, 2001.

254. Parnis SJ, Barker DS, van der Walt JH: Clinical predictors of anaesthetic complications in children with respiratory tract infections. Paediatr Anaesth 11:29–40, 2001.

255. Skolnick ET, Vomvolakis MA, Buck KA, et al: Exposure to environmental tobacco smoke and the risk of adverse respiratory events in children receiving general anesthesia. Anesthesiology 88:1144–1153, 1998.

256. Tait AR, Pandit UA, Voepel-Lewis T, et al: Use of the laryngeal mask airway in children with upper respiratory tract infections: A comparison with endotracheal intubation. Anesth Analg 86:706–711, 1998.

257. Coté CJ: The upper respiratory tract infection (URI) dilemma: Fear of a complication or litigation? Anesthesiology 95:283–285, 2001.

258. Tait AR, Voepel-Lewis T, Munro HM, et al: Cancellation of pediatric outpatient surgery: Economic and emotional implications for patients and their families. J Clin Anesth 9:213–219, 1997.

259. Kain ZN, Mayes LC, Caramico LA, et al: Parental presence during induction of anesthesia. A randomized controlled trial. Anesthesiology 84:1060–1067, 1996.

260. Kain ZN, Mayes LC, Wang SM, et al: Parental presence during induction of anesthesia versus sedative premedication: Which intervention is more effective? Anesthesiology 89:1147–1156, 1998.

261. Kain ZN, Ferris CA, Mayes LC, et al: Parental presence during induction of anaesthesia: Practice differences between the United States and Great Britain. Paediatr Anaesth 6:187–193, 1996.

262. Lin SM, Liu K, Tsai SK, et al: Rectal ketamine versus intranasal ketamine as premedicant in children. Ma Tsui Hsueh Tsa Chi 28:177–183, 1990.

263. Bjerring P, Arendt-Nielsen L: Depth and duration of skin analgesia to needle insertion after topical application of EMLA cream. Br J Anaesth 64:173–177, 1990.

264. Kinouchi K, Tanigami H, Tashiro C, et al: Duration of apnea in anesthetized infants and children required for desaturation of hemoglobin to 95%. The influence of upper respiratory infection. Anesthesiology 77:1105–1107, 1992.

265. Salem MR, Wong AY, Fizzotti GF: Efficacy of cricoid pressure in preventing aspiration of gastric contents in paediatric patients. Br J Anaesth 44:401–404, 1972.

266. Wheeler M: The difficult pediatric airway. In Hagberg C (ed): Handbook of Difficult Airway Management. New York, Churchill Livingstone, 2000, pp 257–300.

267. Practice guidelines for management of the difficult airway. A report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 78:597–602, 1993.

268. Frei FJ, Ummenhofer W: A special mask for teaching fiberoptic intubation in pediatric patients. Anesth Analg 76:458, 1993.

269. Inada T, Fujise K, Tachibana K, et al: Orotracheal intubation through the laryngeal mask airway in paediatric patients with Treacher-Collins syndrome. Paediatr Anaesth 5:129–132, 1995.

270. Osses H, Poblete M, Asenjo F: Laryngeal mask for difficult intubation in children. Paediatr Anaesth 9:399–401, 1999.

271. Bandla HP, Smith DE, Kiernan MP: Laryngeal mask airway facilitated fibreoptic bronchoscopy in infants. Can J Anaesth 44:1242–1247, 1997.

272. Coté CJ, Eavey RD, Todres ID, et al: Cricothyroid membrane puncture: Oxygenation and ventilation in a dog model using an intravenous catheter. Crit Care Med 16:615–619, 1988.

273. Holliday MA, Segar WE: The maintenance need for water in parenteral fluid therapy. Pediatrics 19:823–832, 1957.

274. Sieber FE, Traystman RJ: Special issues: Glucose and the brain. Crit Care Med 20:104–114, 1992.

275. Maekawa N, Mikawa K, Yaku H, et al: Effects of 2-, 4- and 12-hour fasting intervals on preoperative gastric fluid pH and volume, and plasma glucose and lipid homeostasis in children. Acta Anaesthesiol Scand 37:783–787, 1993.

276. Aun CS, Panesar NS: Paediatric glucose homeostasis during anaesthesia. Br J Anaesth 64:413–418, 1990.

277. Graham IF: Preoperative starvation and plasma glucose concentrations in children undergoing outpatient anaesthesia. Br J Anaesth 51:161–164, 1979.

278. Dodd RY: Current viral risks of blood and blood products. Ann Med 32:469–474, 2000.

279. Vrielink H, Reesink HW: Transfusion-transmissible infections. Curr Opin Hematol 5:396–405, 1998.

280. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force. Transfus Med 6:261–271, 1996.

281. Moroff G, Luban NL: The irradiation of blood and blood components to prevent graft-versus-host disease: Technical issues and guidelines. Transfus Med Rev 11:15–26, 1997.

282. Welborn LG, Hannallah RS, Luban NLC, et al: Anemia and postoperative apnea in former preterm infants. Anesthesiology 74:1003–1006, 1991.

283. Coté CJ, Zaslavsky A, Downes JJ, et al: Postoperative apnea in former preterm infants after inguinal herniorrhaphy. A combined analysis. Anesthesiology 82:809–822, 1995.

284. Koshy M, Weiner SJ, Miller ST, et al: Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases. Blood 86:3676–3684, 1995.

285. Vichinsky EP, Haberkern CM, Neumayr L, et al: A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 333:206–213, 1995.

286. Coté CJ: Blood, colloid, and crystalloid therapy. Anesthesiol Clin North Am 9:865–884, 1991.

287. Miller RD: Complications of massive blood transfusions. Anesthesiology 39:82–93, 1973.

288. Barcelona SL, Coté CJ: Pediatric resuscitation in the operating room. Anesthesiol Clin North Am 19:339–365, 2001.

289. Horlocker TT, Nuttall GA, Dekutoski MB, et al: The accuracy of coagulation tests during spinal fusion and instrumentation. Anesth Analg 93:33–38, 2001.

290. Coté CJ, Drop LJ, Hoaglin DC, et al: Ionized hypocalcemia after fresh frozen plasma administration to thermally injured children: Effects of infusion rate, duration, and treatment with calcium chloride. Anesth Analg 67:152–160, 1988.

291. Coté CJ: Depth of halothane anesthesia potentiates citrate-induced ionized hypocalcemia and adverse cardiovascular events in dogs. Anesthesiology 67:676–680, 1987.

292. Coté CJ, Drop LJ, Daniels AL, et al: Calcium chloride versus calcium gluconate: Comparison of ionization and cardiovascular effects in children and dogs. Anesthesiology 66:465–470, 1987.

2406

293. Diaz J, Acosta F, Parrilla P, et al: Correlation among ionized calcium, citrate, and total calcium levels during hepatic transplantation. Clin Biochem 28:315–317, 1995.

294. Coté CJ, Liu LM, Szyfelbein SK, et al: Changes in serial platelet counts following massive blood transfusion in pediatric patients. Anesthesiology 62:197–201, 1985.

295. Stevenson GW, Tobin M, Coté CJ: Potential air embolus with the use of a blood/fluid warming set. Anesth Analg 79:610–611, 1994.

296. Smallman JM, Morgan M: Evaluation of the Level 1 Hotline blood warmer. Anaesthesia 47:869–871, 1992.

297. Presson RGJ, Haselby KA, Bezruczko AP, et al: Evaluation of a new high-efficiency blood warmer for children. Anesthesiology 73:173–176, 1990.

298. Pappas CG, Paddock H, Goyette P, et al: In-line microwave blood warming of in-date human packed red blood cells. Crit Care Med 23:1243–1250, 1995.

299. Booke M, Sielenkamper A: Massive transfusion with the Rapid Infusion System. Its effect on core body temperature [in German]. Anaesthesist 50:926–929, 2001.

300. Barcelona SL, Vilich F, Coté CJ: Comparison of flow rates and warming capabilities of the Level 1 and Rapid Infusion System with various size intravenous catheters. Anesth Analg 97:358–363, 2003.